Teitelbaum I, Glickman J, Neu A, Neumann J, Rivara MB, Shen J, Wallace E, Watnick S, Mehrotra R. KDOQI US Commentary on the 2020 ISPD Practice Recommendations for Prescribing High-Quality Goal-Directed Peritoneal Dialysis. Am J Kidney Dis. 2021 Feb;77(2):157-171. PubMed PMID: 33341315
Vondracek SF, Teitelbaum I, Kiser TH. Principles of Kidney Pharmacotherapy for the Nephrologist: Core Curriculum 2021. Am J Kidney Dis. 2021 Sep;78(3):442-458. PubMed PMID: 34275659
Glickman JD, Teitelbaum I, Golper TA. Prescribing Home Hemodialysis. Adv Chronic Kidney Dis. 2021 Mar;28(2):157-163. PubMed PMID: 34717862
Teitelbaum I. Peritoneal Dialysis. N Engl J Med. 2021 Nov 4;385(19):1786-1795. PubMed PMID: 34731538
Brown EA, Blake PG, Boudville N, Davies S, de Arteaga J, Dong J, Finkelstein F, Foo M, Hurst H, Johnson DW, Johnson M, Liew A, Moraes T, Perl J, Shroff R, Teitelbaum I, Wang AY, Warady B. International Society for Peritoneal Dialysis practice recommendations: Prescribing high-quality goal-directed peritoneal dialysis. Perit Dial Int. 2020 May;40(3):244-253. PubMed PMID: 32063219
Chen CH, Perl J, Teitelbaum I. Prescribing high-quality peritoneal dialysis: The role of preserving residual kidney function. Perit Dial Int. 2020 May;40(3):274-281. PubMed PMID: 32063188
Sahlawi MA, Wilson G, Stallard B, Manera KE, Tong A, Pisoni RL, Fuller DS, Cho Y, Johnson DW, Piraino B, Schreiber MJ, Boudville NC, Teitelbaum I, Perl J. Peritoneal dialysis-associated peritonitis outcomes reported in trials and observational studies: A systematic review. Perit Dial Int. 2020 Mar;40(2):132-140. PubMed PMID: 32063197
Gutman T, Manera KE, Baumgart A, Johnson DW, Wilkie M, Boudville N, Craig JC, Dong J, Jesudason S, Mehrotra R, Neu A, Shen JI, Van Biesen W, Blake PG, Brunier G, Cho Y, Jefferson N, Lenga I, Mann N, Mendelson AA, Perl J, Sanabria RM, Scholes-Roberston N, Schwartz D, Teitelbaum I, Tong A. "Can I go to Glasgow?" Learnings from patient involvement at the 17th Congress of the International Society for Peritoneal Dialysis (ISPD). Perit Dial Int. 2020 Jan;40(1):12-25. PubMed PMID: 32063150
Van Matre ET, Teitelbaum I, Kiser TH. Intravenous and Intraperitoneal Pharmacokinetics of Dalbavancin in Peritoneal Dialysis Patients. Antimicrob Agents Chemother. 2020 Apr 21;64(5). PubMed PMID: 32122898
Teitelbaum I. Delivering High-Quality Peritoneal Dialysis: What Really Matters?. Clin J Am Soc Nephrol. 2020 Jun 11. [Epub ahead of print] PubMed PMID: 32527946
Gutman T, Manera KE, Baumgart A, Johnson DW, Wilkie M, Boudville N, Craig JC, Dong J, Jesudason S, Mehrotra R, Neu A, Shen JI, Van Biesen W, Blake PG, Brunier G, Cho Y, Jefferson N, Lenga I, Mann N, Mendelson AA, Perl J, Sanabria RM, Scholes-Roberston N, Schwartz D, Teitelbaum I, Tong A. "Can I go to Glasgow?" Learnings from patient involvement at the 17th Congress of the International Society for Peritoneal Dialysis (ISPD). Perit Dial Int. 2020 Jan;40(1):12-25. PubMed PMID: 32063150
Sahlawi MA, Wilson G, Stallard B, Manera KE, Tong A, Pisoni RL, Fuller DS, Cho Y, Johnson DW, Piraino B, Schreiber MJ, Boudville NC, Teitelbaum I, Perl J. Peritoneal dialysis-associated peritonitis outcomes reported in trials and observational studies: A systematic review. Perit Dial Int. 2020 Mar;40(2):132-140. PubMed PMID: 32063197
Brown EA, Blake PG, Boudville N, Davies S, de Arteaga J, Dong J, Finkelstein F, Foo M, Hurst H, Johnson DW, Johnson M, Liew A, Moraes T, Perl J, Shroff R, Teitelbaum I, Wang AY, Warady B. International Society for Peritoneal Dialysis practice recommendations: Prescribing high-quality goal-directed peritoneal dialysis. Perit Dial Int. 2020 May;40(3):244-253. PubMed PMID: 32063219
Chen CH, Perl J, Teitelbaum I. Prescribing high-quality peritoneal dialysis: The role of preserving residual kidney function. Perit Dial Int. 2020 May;40(3):274-281. PubMed PMID: 32063188
Perl J, Fuller DS, Bieber BA, Boudville N, Kanjanabuch T, Ito Y, Nessim SJ, Piraino BM, Pisoni RL, Robinson BM, Schaubel DE, Schreiber MJ, Teitelbaum I, Woodrow G, Zhao J, Johnson DW. Peritoneal Dialysis-Related Infection Rates and Outcomes: Results From the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS). Am J Kidney Dis. 2020 Jul;76(1):42-53. PubMed PMID: 31932094
Van Matre ET, Teitelbaum I, Kiser TH. Intravenous and Intraperitoneal Pharmacokinetics of Dalbavancin in Peritoneal Dialysis Patients. Antimicrob Agents Chemother. 2020 Apr 21;64(5). PubMed PMID: 32122898
Teitelbaum I. Delivering High-Quality Peritoneal Dialysis: What Really Matters?. Clin J Am Soc Nephrol. 2020 Nov 6;15(11):1663-1665. PubMed PMID: 32527946
Shen JI, Schreiber MJ, Zhao J, Robinson BM, Pisoni RL, Mehrotra R, Oliver MJ, Tomo T, Tungsanga K, Teitelbaum I, Ghaffari A, Lambie M, Perl J. Attitudes toward Peritoneal Dialysis among Peritoneal Dialysis and Hemodialysis Medical Directors: Are We Preaching to the Right Choir?. Clin J Am Soc Nephrol. 2019 Jul 5;14(7):1067-1070. PubMed PMID: 31278114
Haivas CD, Teitelbaum I. Eradication of Repeated Episodes of Coagulase-Negative Staphylococcus Peritonitis: a Multipronged Approach. Perit Dial Int. 2019 Nov-Dec;39(6):568-570. PubMed PMID: 31690701
Ambruso SL, Teitelbaum I. Prevention of Peritoneal Dialysis Drop-Out. Adv Perit Dial. 2018 Nov;34(2018):19-23. PubMed PMID: 30480532
Teitelbaum I. Crafting the Prescription for Patients Starting Peritoneal Dialysis. Clin J Am Soc Nephrol. 2018 Mar 7;13(3):483-485. PubMed PMID: 29382652